Acute gastrointestinal bleeding as the presenting manifestation of prostate Cancer
暂无分享,去创建一个
[1] H. G. Taylor,et al. Atypical Metastasis From Prostate Cancer: Clinical Utility of the Immunoperoxidase Technique for Prostate-Specific Antigen , 1985 .
[2] S. Goldenberg,et al. Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy. , 1983, Urology.
[3] C. Li,et al. Prostatic cancer presenting as metastatic adenocarcinoma of undetermined origin: Immunodiagnosis by prostatic acid phosphatase , 1983, Cancer.
[4] D. Cornfield,et al. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma. , 1982, Southern medical journal.
[5] G. Murphy,et al. A prostate antigen in sera of prostatic cancer patients. , 1980, Cancer research.
[6] W. Swaim,et al. Disseminated intravascular coagulation in the urologic patient. , 1976, The Journal of urology.
[7] M. Abeloff,et al. Spontaneous remission of recurring disseminated intravascular coagulation associated with prostatic carcinoma , 1976, Cancer.
[8] S. Goodnight. BLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY: A REVIEW , 1974, Annals of the New York Academy of Sciences.
[9] A. Thomas. Chronic intravascular coagulation in metastatic prostate cancer , 1973 .
[10] N. C. Bruns,et al. Chronic intravascular coagulation in metastatic prostate cancer. , 1973, Archives of surgery.
[11] P. Straub,et al. Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparin , 1967, Journal of clinical pathology.
[12] L. L. Phillips,et al. Manifestation and management of hypofibrinogenemia and firinolysis in patients with carcinoma of the prostate. , 1966, The Journal of urology.
[13] J. L. Sommer,et al. Experimental pyelonephritis in the rat with observations on ureteral reflux. , 1961, The Journal of urology.
[14] L. L. Phillips,et al. The fibrinolytic enzyme system in prostatic cancer , 1959, Cancer.
[15] S. Rapaport,et al. Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma. , 1959, The American journal of medicine.
[16] F. Schilling,et al. Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases. , 1958, Annals of internal medicine.
[17] O. Daniel,et al. Dangerous Bleeding Associated with Carcinoma of Prostate , 1957, British medical journal.
[18] W. Whitmore,et al. Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate. , 1953, The American journal of medicine.
[19] W. Whitmore,et al. The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate , 1953, Cancer.
[20] W. Whitmore,et al. Fibrinolysis in metastatic cancer of the prostate , 1952, Cancer.
[21] W. Isaacs,et al. Extracorporeal shock wave therapy decreases COX‐2 by inhibiting TLR4‐NFκB pathway in a prostatitis rat model , 2019, The Prostate.
[22] A. Little,et al. Protochemotherapy in non‐small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report , 1986, Cancer.